DNA/NN
Methylation/NN
Profiles/NNS
of/IN
Blood/NN
Cells/NNS
Are/NN
Distinct/JJ
between/IN
Early-Onset/NN
Obese/JJ
and/CC
Control/NN
Individuals/NNS
./.
====================
Obesity/NN
is/VBZ
a/DT
highly/RB
prevalent/JJ
,/,
chronic/JJ
disorder/NN
that/WDT
has/VBZ
been/VBN
increasing/VBG
in/IN
incidence/NN
in/IN
young/JJ
patients/NNS
./.
====================
Both/DT
epigenetic/JJ
and/CC
genetic/JJ
aberrations/NNS
may/MD
play/VB
a/DT
role/NN
in/IN
the/DT
pathogenesis/NN
of/IN
obesity/NN
./.
====================
Therefore/RB
,/,
in-depth/RB
epigenomic/JJ
and/CC
genomic/JJ
analyses/NNS
will/MD
advance/VB
our/PRP$
understanding/NN
of/IN
the/DT
detailed/JJ
molecular/JJ
mechanisms/NNS
underlying/VBG
obesity/NN
and/CC
aid/VB
in/IN
the/DT
selection/NN
of/IN
potential/JJ
biomarkers/NNS
for/IN
obesity/NN
in/IN
youth/JJ
./.
====================
Here/RB
,/,
we/PRP
performed/VBD
microarray-based/VBN
DNA/NN
methylation/NN
and/CC
gene/NN
expression/NN
profiling/VBG
of/IN
peripheral/JJ
white/JJ
blood/NN
cells/NNS
obtained/VBN
from/IN
six/CD
young/JJ
,/,
obese/DT
individuals/NNS
and/CC
six/CD
healthy/JJ
controls/NNS
./.
====================
We/PRP
observed/VBD
that/IN
the/DT
hierarchical/JJ
clustering/NN
of/IN
DNA/NN
methylation/NN
,/,
but/CC
not/RB
gene/NN
expression/NN
,/,
clearly/RB
segregates/VBZ
the/DT
obese/JJ
individuals/NNS
from/IN
the/DT
controls/NNS
,/,
suggesting/VBG
that/IN
the/DT
metabolic/JJ
disturbance/NN
that/DT
occurs/VBZ
as/IN
a/DT
result/NN
of/IN
obesity/NN
at/IN
a/DT
young/JJ
age/NN
may/MD
affect/VB
the/DT
DNA/NN
methylation/NN
of/IN
peripheral/JJ
blood/NN
cells/NNS
without/IN
accompanying/VBG
transcriptional/JJ
changes/NNS
./.
====================
To/TO
examine/VB
the/DT
genome-wide/NN
differences/NNS
in/IN
the/DT
DNA/NN
methylation/NN
profiles/NNS
of/IN
young/JJ
obese/DT
and/CC
control/NN
individuals/NNS
,/,
we/PRP
identified/VBD
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
and/CC
investigated/VBD
their/PRP$
genomic/JJ
and/CC
epigenomic/JJ
contexts/VBZ
./.
====================
The/DT
aberrant/JJ
DNA/NN
methylation/NN
patterns/NNS
in/IN
obese/DT
individuals/NNS
can/MD
be/VB
summarized/VBN
as/IN
relative/JJ
gains/NNS
and/CC
losses/NNS
of/IN
DNA/NN
methylation/NN
in/IN
gene/NN
promoters/NNS
and/CC
gene/NN
bodies/NNS
,/,
respectively/RB
./.
====================
We/PRP
also/RB
observed/VBN
that/IN
the/DT
CpG/NN
islands/NNS
of/IN
obese/DT
individuals/NNS
are/VBP
more/RBR
susceptible/JJ
to/TO
DNA/NN
methylation/NN
compared/VBN
to/TO
controls/NNS
./.
====================
Our/PRP$
pilot/NN
study/NN
suggests/VBZ
that/IN
the/DT
genome-wide/NN
aberrant/JJ
DNA/NN
methylation/NN
patterns/NNS
of/IN
obese/DT
individuals/NNS
may/MD
advance/VB
not/RB
only/RB
our/PRP$
understanding/NN
of/IN
the/DT
epigenomic/JJ
pathogenesis/NN
but/CC
also/RB
early/JJ
screening/NN
of/IN
obesity/NN
in/IN
youth/JJ
./.
====================
Obesity/NN
is/VBZ
a/DT
disorder/NN
defined/VBN
by/IN
excessive/JJ
adiposity/NN
./.
====================
Given/IN
that/DT
approximately/RB
3/CD
million/NN
people/JJ
die/VBP
due/JJ
to/TO
complications/NNS
from/IN
being/VBG
overweight/VBN
each/DT
year/NN
worldwide/NN
,/,
the/DT
steadily/RB
increasing/VBG
number/NN
of/IN
overweight/JJ
individuals/NNS
will/MD
pose/VB
a/DT
major/JJ
threat/NN
to/TO
public/JJ
health/NN
[/(
1/CD
]/)
./.
====================
Notably/RB
,/,
the/DT
prevalence/NN
of/IN
obesity/NN
in/IN
children/NN
has/VBZ
increased/VBN
in/IN
recent/JJ
years/NNS
,/,
and/CC
addressing/VBG
childhood/NN
obesity/NN
has/VBZ
become/VBN
one/CD
of/IN
the/DT
major/JJ
challenges/NNS
in/IN
the/DT
field/NN
of/IN
public/JJ
health/NN
./.
====================
In/IN
addition/NN
to/TO
a/DT
number/NN
of/IN
modifiable/JJ
risk/NN
factors/NNS
,/,
including/VBG
the/DT
social/JJ
and/CC
cultural/JJ
environment/NN
of/IN
an/DT
individual/JJ
,/,
certain/JJ
genetic/JJ
factors/NNS
can/MD
contribute/VB
to/TO
an/DT
increased/VBN
susceptibility/NN
to/TO
obesity/NN
./.
====================
Genome-wide/NN
association/NN
studies/NNS
have/VBP
identified/VBN
several/JJ
candidate/NN
genomic/JJ
variants/NNS
on/IN
the/DT
LEP/NN
(/(
leptin/NN
)/)
,/,
IGF2/NN
,/,
and/CC
POMC/NN
genes/NNS
[/(
23/CD
]/)
./.
====================
However/RB
,/,
such/JJ
variants/NNS
are/VBP
observed/VBN
in/IN
only/RB
a/DT
minority/NN
of/IN
obese/DT
individuals/NNS
,/,
leaving/VBG
a/DT
majority/NN
of/IN
obese/DT
people/JJ
without/IN
the/DT
identification/NN
of/IN
causal/JJ
genomic/JJ
factors/NNS
[/(
4/CD
]/)
./.
====================
Moreover/RB
,/,
some/DT
studies/NNS
failed/VBD
to/TO
identify/VB
a/DT
strong/JJ
association/NN
between/IN
the/DT
development/NN
of/IN
obesity/NN
in/IN
children/NN
and/CC
in/IN
their/PRP$
parents/NNS
[/(
56/CD
]/)
./.
====================
Thus/RB
,/,
the/DT
causal/JJ
role/NN
of/IN
genetics/NNS
in/IN
the/DT
etiology/NN
of/IN
childhood/NN
obesity/NN
is/VBZ
unclear/JJ
,/,
suggesting/VBG
that/IN
non-genetic/JJ
factors/NNS
,/,
including/VBG
behavioral/JJ
or/CC
environmental/JJ
ones/NNS
,/,
should/MD
be/VB
taken/VBN
into/IN
account/VBP
./.
====================
Recently/RB
,/,
the/DT
role/NN
of/IN
epigenetic/JJ
regulation/NN
in/IN
the/DT
pathogenesis/NN
of/IN
multifactorial/JJ
disorders/NNS
,/,
including/VBG
obesity/NN
,/,
has/VBZ
been/VBN
recognized/VBN
[/(
7/CD
]/)
./.
====================
With/IN
the/DT
advent/JJ
of/IN
high-throughput/JJ
DNA/NN
methylation/NN
profiling/VBG
technologies/NNS
,/,
it/PRP
is/VBZ
now/RB
possible/JJ
to/TO
discover/RB
novel/JJ
genes/NNS
and/CC
markers/NNS
for/IN
the/DT
early/JJ
screening/NN
and/CC
accurate/VBP
diagnosis/NN
of/IN
obesity/NN
on/IN
a/DT
genome-wide/JJ
scale/NN
./.
====================
For/IN
example/NN
,/,
Wang/NNP
et/FW
al/JJ
./.
====================
[/(
8/CD
]/)
compared/VBN
the/DT
DNA/NN
methylation/NN
profiles/NNS
obtained/VBN
from/IN
the/DT
peripheral/JJ
blood/NN
cells/NNS
of/IN
seven/CD
young/JJ
obese/DT
and/CC
seven/CD
normal/JJ
individuals/NNS
using/VBG
the/DT
Illumina/NN
HumanMethylation27/NN
BeadChip/NN
Kit/NN
,/,
with/IN
a/DT
resolution/NN
of/IN
~27,000/CD
CpG/NN
sites/NNS
./.
====================
They/PRP
identified/VBD
a/DT
number/NN
of/IN
potential/JJ
markers/NNS
(/(
e.g./FW
,/,
CpG/NN
sites/NNS
located/JJ
at/IN
the/DT
promoters/NNS
of/IN
UBASH3A/NN
and/CC
TRIM3/NN
)/)
that/WDT
showed/VBD
differential/JJ
methylation/NN
between/IN
obese/DT
and/CC
control/NN
individuals/NNS
and/CC
subsequently/RB
validated/VBN
the/DT
loci/NNS
with/IN
pyrosequencing/JJ
./.
====================
Almen/RB
et/FW
al/JJ
./.
====================
[/(
9/CD
]/)
used/VBN
the/DT
same/JJ
chip/NN
to/TO
identify/VB
DNA/NN
methylation/NN
markers/NNS
associated/VBN
with/IN
both/CC
age/NN
and/CC
obesity/NN
./.
====================
Since/IN
these/DT
genome-wide/NN
studies/NNS
have/VBP
mainly/RB
focused/VBN
on/IN
marker/NN
discovery/RB
,/,
in-depth/RB
genomic/JJ
analyses/NNS
(/(
e.g./FW
,/,
exploration/NN
of/IN
the/DT
relationship/NN
between/IN
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
and/CC
other/JJ
genomic/JJ
features/NNS
or/CC
gene/NN
expression/NN
)/)
are/VBP
still/RB
largely/RB
uninvestigated/JJ
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
performed/VBD
genome-wide/IN
DNA/NN
methylation/NN
and/CC
transcriptome/JJ
profiling/VBG
of/IN
young/JJ
obese/DT
individuals/NNS
compared/VBN
with/IN
healthy/JJ
controls/NNS
(/(
n/NN
=/JJ
6/CD
for/IN
both/DT
groups/NNS
)/)
to/TO
examine/VB
whether/IN
changes/NNS
in/IN
DNA/NN
methylation/NN
or/CC
gene/NN
expression/NN
in/IN
peripheral/JJ
blood/NN
cells/NNS
could/MD
distinguish/VB
obese/DT
individuals/NNS
from/IN
controls/NNS
./.
====================
For/IN
methylation/NN
profiling/VBG
,/,
we/PRP
used/VBD
the/DT
methylation/NN
microarray/NN
with/IN
the/DT
highest/JJS
resolution/NN
currently/RB
available—the/DT
Illumina/NN
HumanMethylation450/CD
platform/NN
,/,
with/IN
a/DT
resolution/NN
of/IN
~485,000/CD
CpG/NN
sites—to/NN
ensure/VBP
proper/JJ
genomic/JJ
correlative/JJ
analyses/NNS
./.
====================
Recognizing/VBG
that/IN
DNA/NN
methylation/NN
can/MD
be/VB
used/VBN
as/IN
a/DT
predictive/JJ
marker/NN
for/IN
obesity/NN
,/,
we/PRP
next/RB
performed/VBN
genomic/JJ
correlative/JJ
analyses/NNS
of/IN
the/DT
DNA/NN
methylation/NN
patterns/NNS
obtained/VBN
during/IN
profiling/VBG
to/TO
identify/VB
enrichment/JJ
patterns/NNS
of/IN
CpG/NN
sites/NNS
that/IN
were/VBD
differentially/RB
methylated/VBN
between/IN
obese/DT
and/CC
control/JJ
individuals/NNS
with/IN
respect/NN
to/TO
genes/NNS
,/,
CpG/NN
islands/VBZ
(/(
CGIs/NNS
)/)
,/,
and/CC
epigenomic/JJ
compartments/NNS
./.
====================
The/DT
putative/JJ
functions/NNS
of/IN
those/DT
genes/NNS
harboring/VBG
the/DT
differentially/RB
methylated/VBN
CpGs/NNS
were/VBD
also/RB
investigated/VBD
./.
====================
Patient/JJ
and/CC
control/NN
samples/NNS
====================
The/DT
subjects/NNS
in/IN
this/DT
study/NN
were/VBD
selected/VBN
from/IN
a/DT
cohort/JJ
that/DT
was/VBD
part/NN
of/IN
a/DT
community-based/JJ
prevention/NN
and/CC
management/JJ
program/NN
of/IN
childhood/NN
obesity/NN
in/IN
a/DT
rural/JJ
area/NN
of/IN
Korea/NN
(/(
Chungju/NNP
,/,
Chungcheongbuk-do/NNP
)/)
./.
====================
Twelve/CD
participants/NNS
,/,
six/CD
obese/DT
children/NN
with/IN
a/DT
high/JJ
body/NN
mass/NN
index/NN
and/CC
six/CD
children/NN
with/IN
a/DT
normal/JJ
body/NN
weight/NN
,/,
were/VBD
randomly/RB
selected/VBN
for/IN
this/DT
pilot/NN
study/NN
(/(
Table/JJ
1/CD
)/)
./.
====================
All/DT
individuals/NNS
were/VBD
12–13/CD
years/NNS
old/JJ
,/,
male/JJ
and/CC
had/VBD
an/DT
East/JJ
Asian/JJ
ancestry/NN
./.
====================
Since/IN
the/DT
subjects/NNS
of/IN
this/DT
study/NN
were/VBD
minors/NNS
,/,
informed/VBN
consent/NN
for/IN
all/DT
individuals/NNS
was/VBD
obtained/VBN
in/IN
written/CD
format/IN
both/CC
from/IN
the/DT
participants/NNS
and/CC
their/PRP$
parents/NNS
./.
====================
This/DT
study/NN
,/,
including/VBG
the/DT
consent/JJ
procedure/NN
,/,
has/VBZ
been/VBN
approved/VBN
by/IN
the/DT
Institutional/JJ
Review/NN
Board/JJ
(/(
KIRB-00524-010/NN
)/)
at/IN
The/DT
Catholic/JJ
University/NN
of/IN
Korea/NN
,/,
College/NN
of/IN
Medicine/NN
./.
====================
DNA/NN
methylation/NN
and/CC
expression/NN
profiling/VBG
====================
The/DT
samples/NNS
for/IN
DNA/NN
methylation/NN
and/CC
gene/NN
expression/NN
profiling/VBG
experiments/NNS
were/VBD
prepared/VBN
as/IN
follows/VBZ
./.
====================
Blood/NN
from/IN
each/DT
individual/JJ
was/VBD
collected/VBN
into/IN
two/CD
EDTA/NN
tubes/NNS
(/(
3/CD
mL/NN
)/)
./.
====================
After/IN
the/DT
contents/NNS
had/VBD
been/VBN
sufficiently/RB
mixed/JJ
for/IN
5/CD
min/NN
,/,
the/DT
tubes/NNS
were/VBD
stored/VBN
in/IN
a/DT
refrigerator/NN
./.
====================
The/DT
genomic/JJ
DNA/NN
and/CC
total/JJ
RNA/NN
were/VBD
extracted/VBN
using/VBG
DNeasy/JJ
and/CC
RNeasy/NN
Blood/NN
and/CC
Tissue/NN
Kits/NNS
(/(
Qiagen/NN
,/,
Hilden/JJ
,/,
Germany/NNP
)/)
according/VBG
to/TO
the/DT
manufacturer/NN
's/POS
protocol/NN
./.
====================
Bisulfite/NN
conversion/NN
of/IN
genomic/JJ
DNA/NN
was/VBD
carried/VBN
out/RP
using/VBG
an/DT
EZ/NN
DNA/NN
methylation/NN
kit/NN
from/IN
Zymo/NN
Research/NN
(/(
Irvine/NNP
,/,
CA/NNP
,/,
USA/NNP
)/)
,/,
and/CC
DNA/NN
methylation/NN
profiles/NNS
were/VBD
generated/VBN
using/VBG
the/DT
Illumina/NN
HumanMethylation450/NNP
platform/NN
(/(
Illumina/NN
Inc./NNP
,/,
San/NNP
Diego/JJ
,/,
CA/NNP
,/,
USA/NNP
)/)
./.
====================
Background/JJ
correction/NN
and/CC
dye/NN
bias/NNS
equalization/NN
were/VBD
conducted/VBN
using/VBG
methylumi/NN
and/CC
lumi/NN
packages/NNS
in/IN
R/NN
,/,
respectively/RB
./.
====================
Then/RB
,/,
the/DT
data/NNS
was/VBD
normalized/VBN
using/VBG
the/DT
beta/NN
mixture/NN
quantile/JJ
method/NN
[/(
10/CD
]/)
./.
====================
The/DT
methylation/NN
levels/NNS
of/IN
individual/JJ
CpG/NN
sites/NNS
were/VBD
estimated/VBN
as/IN
beta-values/NNS
,/,
which/WDT
are/VBP
the/DT
ratio/NN
of/IN
intensities/NNS
between/IN
locus-specific/JJ
methylated/VBN
and/CC
unmethylated/JJ
bead-bound/VBD
probes/NNS
./.
====================
For/IN
statistical/JJ
analysis/NN
,/,
the/DT
DNA/NN
methylation/NN
level/NN
at/IN
each/DT
CpG/NN
site/NN
was/VBD
converted/VBN
to/TO
an/DT
M-value/NN
using/VBG
the/DT
logit/NN
transformation/NN
as/IN
recommended/VBN
by/IN
Du/FW
et/FW
al/JJ
./.
====================
[/(
11/CD
]/)
and/CC
Marabita/NN
et/FW
al/JJ
./.
====================
[/(
12/CD
]/)
./.
====================
The/DT
probes/NNS
annotated/JJ
as/IN
NCBI/NN
's/POS
reference/NN
SNP/NN
ID/NN
(/(
rs/NNS
ID/NN
)/)
numbers/NNS
were/VBD
removed/VBN
,/,
then/RB
the/DT
methylation/NN
status/NN
of/IN
a/DT
total/JJ
of/IN
485,512/CD
CpG/NN
sites/NNS
were/VBD
used/VBN
for/IN
the/DT
analysis/NN
./.
====================
Genome-wide/NN
gene/NN
expression/NN
levels/NNS
were/VBD
measured/VBN
using/VBG
an/DT
Illumina/NN
Human/JJ
HT-12/NN
v4/NN
Expression/NN
BeadChip/NN
Kit/NN
,/,
with/IN
47,318/CD
probes/NNS
./.
====================
The/DT
extraction/NN
of/IN
raw/NN
data/NNS
and/CC
the/DT
subsequent/JJ
preprocessing/VBG
were/VBD
performed/VBN
using/VBG
the/DT
Illumina/NN
GenomeStudio/NN
software/JJ
according/VBG
to/TO
the/DT
manufacturer/NN
's/POS
instructions/NNS
./.
====================
The/DT
obtained/VBN
expression/NN
profiles/NNS
were/VBD
then/RB
quantile/RB
normalized/VBN
using/VBG
the/DT
R/NN
preprocessCore/VBP
package/NN
./.
====================
The/DT
DNA/NN
methylation/NN
and/CC
DNA/NN
expression/NN
profile/NN
datasets/NNS
were/VBD
submitted/VBN
to/TO
ArrayExpress/NN
(/(
accession/NN
numbers/NNS
E-MTAB-3757/NN
and/CC
E-MTAB-3753/NN
,/,
respectively/RB
)/)
./.
====================
DNA/NN
and/CC
RNA/NN
from/IN
12/CD
subjects/NNS
were/VBD
loaded/VBN
onto/IN
a/DT
single/JJ
12-well/NN
chip/NN
for/IN
methylation/NN
and/CC
gene/NN
expression/NN
analyses/NNS
,/,
respectively/RB
,/,
so/RB
that/IN
batch/VBP
effect/NN
adjustment/JJ
did/VBD
not/RB
need/VBN
to/TO
be/VB
considered/VBN
./.
====================
Unsupervised/JJ
clustering/NN
====================
Hierarchical/JJ
clustering/NN
for/IN
both/DT
gene/NN
expression/NN
and/CC
DNA/NN
methylation/NN
was/VBD
carried/VBN
out/RP
using/VBG
the/DT
R/NN
package/NN
./.
====================
Euclidean/JJ
distance/NN
was/VBD
used/VBN
as/IN
a/DT
distance/NN
metric/JJ
,/,
and/CC
single-linkage/JJ
clustering/NN
was/VBD
adopted/VBN
./.
====================
For/IN
gene/NN
expression/NN
profiles/NNS
,/,
highly/RB
variable/JJ
genes/NNS
were/VBD
selected/VBN
using/VBG
the/DT
mean/JJ
absolute/JJ
deviation/NN
,/,
and/CC
clustering/NN
analyses/NNS
were/VBD
conducted/VBN
using/VBG
these/DT
1,000/CD
selected/VBN
genes/NNS
./.
====================
Statistical/JJ
analysis/NN
====================
Hypermethylated/JJ
and/CC
hypomethylated/VBN
CpG/NN
sites/NNS
identified/VBD
in/IN
each/DT
sample/NN
were/VBD
partitioned/VBN
using/VBG
a/DT
Gaussian/JJ
mixture/NN
model/NN
[/(
13/CD
]/)
,/,
based/VBN
on/IN
the/DT
distribution/NN
of/IN
the/DT
M-values/NNS
in/IN
each/DT
sample/NN
./.
====================
For/IN
each/DT
sample/NN
,/,
the/DT
Expectation-Maximization/NN
algorithm/NN
was/VBD
run/JJ
100/CD
times/NNS
with/IN
different/JJ
seed/VBD
values/NNS
,/,
and/CC
the/DT
model/NN
with/IN
the/DT
largest/JJS
likelihood/NN
value/NN
was/VBD
chosen/NN
as/IN
the/DT
best-fit/NN
model/NN
within/IN
the/DT
100/CD
experiments/NNS
./.
====================
Then/RB
,/,
the/DT
hyper/NN
methylated/VBN
and/CC
hypomethylated/VBN
CpG/NN
sites/NNS
in/IN
each/DT
sample/NN
were/VBD
assigned/VBN
by/IN
selecting/VBG
the/DT
component/NN
with/IN
the/DT
bigger/NN
corresponding/VBG
posterior/JJ
probability/NN
./.
====================
The/DT
analyses/NNS
were/VBD
performed/VBN
using/VBG
the/DT
R/NN
mixtools/NNS
package/NN
[/(
14/CD
]/)
./.
====================
The/DT
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
and/CC
the/DT
differentially/RB
expressed/VBN
genes/NNS
were/VBD
identified/VBN
using/VBG
the/DT
empirical/JJ
Bayes/NNS
model/NN
implemented/JJ
in/IN
the/DT
limma/NN
package/NN
[/(
15/CD
]/)
./.
====================
Chromatic/JJ
region/NN
identification/NN
====================
Chromatin/NN
statuses/NNS
were/VBD
obtained/VBN
from/IN
ChromHMM/NN
results/NNS
[/(
16/CD
]/)
,/,
coordinated/VBD
using/VBG
human/JJ
genome/NN
build/JJ
37/CD
(/(
hg19/NN
)/)
,/,
which/WDT
was/VBD
downloaded/VBN
from/IN
the/DT
University/JJ
of/IN
California/NN
,/,
Santa/NN
Cruz/NN
(/(
UCSC/NN
)/)
Encyclopedia/NN
of/IN
DNA/NN
Elements/NNS
(/(
ENCODE/NN
)/)
as/IN
a/DT
Browser/JJ
Extensible/JJ
Data/NNS
(/(
BED/NN
)/)
format/IN
./.
====================
The/DT
chromatin/NN
state/NN
at/IN
the/DT
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
was/VBD
determined/VBN
by/IN
finding/VBG
overlaps/VBZ
with/IN
the/DT
regions/NNS
defined/VBN
in/IN
the/DT
dataset/NN
given/VBN
in/IN
the/DT
software/JJ
./.
====================
Differences/NNS
in/IN
DNA/NN
methylation/NN
and/CC
gene/NN
expression/NN
patterns/NNS
between/IN
obese/DT
and/CC
normal/JJ
individuals/NNS
====================
We/PRP
first/RB
investigated/VBD
whether/IN
gene/NN
expression/NN
levels/NNS
and/or/CC
DNA/NN
methylation/NN
profiles/NNS
can/MD
distinguish/VB
obese/DT
individuals/NNS
from/IN
control/JJ
individuals/NNS
with/IN
normal/JJ
body/NN
weights/NNS
(/(
n/NN
=/JJ
6/CD
in/IN
each/DT
group/NN
)/)
./.
====================
To/TO
this/DT
end/NN
,/,
we/PRP
performed/VBD
unsupervised/JJ
hierarchical/JJ
clustering/NN
analyses/NNS
using/VBG
gene/NN
expression/NN
profiles/NNS
./.
====================
No/DT
clear/JJ
segregation/NN
was/VBD
observed/VBN
between/IN
the/DT
obese/JJ
and/CC
control/NN
individuals/NNS
using/VBG
the/DT
gene/NN
expression/NN
profiles/NNS
(/(
Fig/NN
./.
====================
1A/NN
)/)
./.
====================
In/IN
contrast/NN
to/TO
gene/NN
expression/NN
,/,
hierarchical/JJ
clustering/NN
using/VBG
DNA/NN
methylation/NN
profiling/VBG
revealed/VBD
a/DT
unique/JJ
cluster/NN
of/IN
obese/DT
individuals/NNS
that/WDT
was/VBD
segregated/VBN
from/IN
the/DT
controls/NNS
(/(
Fig/NN
./.
====================
1B/NN
)/)
,/,
suggesting/VBG
that/IN
the/DT
obese/JJ
individuals/NNS
may/MD
harbor/VB
characteristic/JJ
epigenetic/JJ
marks/NNS
in/IN
their/PRP$
blood/NN
cells/NNS
./.
====================
We/PRP
next/RB
investigated/VBD
the/DT
global/JJ
distribution/NN
of/IN
DNA/NN
methylation/NN
levels/NNS
of/IN
all/DT
CpG/NN
sites/NNS
examined/VBN
across/IN
the/DT
12/CD
individuals/NNS
./.
====================
The/DT
distribution/NN
of/IN
beta-values/NNS
(/(
Fig/NN
./.
====================
1C/NN
)/)
showed/VBD
a/DT
bimodal/JJ
distribution/NN
whose/WP$
two/CD
peaks/NNS
correspond/VBP
to/TO
the/DT
hypomethylated/JJ
and/CC
hypermethylated/JJ
CpG/NN
sites/NNS
./.
====================
After/IN
transforming/VBG
the/DT
beta-values/NNS
to/TO
M-values/NNS
(/(
Fig/NN
./.
====================
1D/CD
)/)
,/,
we/PRP
divided/VBD
the/DT
DNA/NN
methylation/NN
sites/NNS
into/IN
hypomethylated/JJ
and/CC
hypermethylated/JJ
CpG/NN
sites/NNS
using/VBG
the/DT
Gaussian/JJ
mixture/NN
model/NN
./.
====================
Boxplots/NNS
of/IN
M-values/NNS
corresponding/VBG
to/TO
hypomethylated/VBN
and/CC
hypermethylated/JJ
CpG/NN
sites/NNS
are/VBP
shown/VBN
for/IN
each/DT
sample/NN
in/IN
Fig/NN
./.
====================
1E/NN
and/CC
1F/NN
,/,
respectively/RB
./.
====================
Of/IN
note/NN
,/,
when/WRB
sorted/VBN
by/IN
median/JJ
value/NN
,/,
a/DT
clear/JJ
segregation/NN
of/IN
obese/DT
individuals/NNS
from/IN
controls/NNS
was/VBD
observed/VBN
in/IN
both/CC
profiles/NNS
./.
====================
M-values/NNS
representing/VBG
hypomethylated/VBN
CpG/NN
sites/NNS
skewed/VBD
higher/JJR
for/IN
obese/DT
individuals/NNS
compared/VBN
with/IN
controls/NNS
,/,
and/CC
the/DT
resulting/VBG
shift/NN
in/IN
median/JJ
values/NNS
was/VBD
responsible/JJ
for/IN
the/DT
segregation/NN
of/IN
obese/DT
and/CC
control/JJ
individuals/NNS
(/(
p/NN
≈/CD
0.0/CD
for/IN
all/DT
normal/JJ
vs./CC
all/DT
obese/DT
;/:
one-tailed/VBN
t/NN
test/NN
)/)
(/(
Fig/NN
./.
====================
1E/NN
)/)
./.
====================
In/IN
addition/NN
,/,
the/DT
hypermethylated/JJ
CpG/NN
sites/NNS
of/IN
obese/DT
individuals/NNS
tended/VBD
to/TO
have/VB
lower/JJR
M-values/NNS
compared/VBN
to/TO
controls/NNS
(/(
p/NN
≈/CD
0.0/CD
for/IN
all/DT
obese/DT
vs./CC
all/DT
normal/JJ
;/:
one-tailed/VBN
t/NN
test/NN
)/)
(/(
Fig/NN
./.
====================
1F/CD
)/)
./.
====================
The/DT
overall/JJ
M-value/NN
distribution/NN
between/IN
obese/DT
and/CC
control/NN
individuals/NNS
suggests/VBZ
that/IN
the/DT
difference/NN
in/IN
methylation/NN
between/IN
two/CD
groups/NNS
may/MD
be/VB
subtle/JJ
,/,
but/CC
our/PRP$
analyses/NNS
revealed/VBD
the/DT
CpG/NN
sites/NNS
in/IN
obese/DT
individuals/NNS
may/MD
have/VB
less/RBR
frequent/JJ
hypomethylation/NN
and/CC
hypermethylation/NN
compared/VBN
to/TO
controls/NNS
./.
====================
The/DT
extent/NN
of/IN
DNA/NN
methylation/NN
varies/VBZ
across/IN
the/DT
genome/NN
====================
To/TO
investigate/VB
the/DT
level/NN
of/IN
CpG/NN
methylation/NN
with/IN
respect/NN
to/TO
nearby/JJ
genes/NNS
or/CC
CGIs/NNS
,/,
we/PRP
categorized/VBD
the/DT
CpG/NN
sites/NNS
into/IN
six/CD
regional/JJ
categories/NNS
:/:
the/DT
3′/NN
untranslated/JJ
region/NN
(/(
UTR/NN
)/)
,/,
5′/CD
UTR/NN
,/,
first/JJ
exon/NN
,/,
gene/NN
body/NN
,/,
TSS200/CD
,/,
and/CC
TSS1500/CD
./.
====================
TSS200/CD
and/CC
TSS1500/CD
represent/VBP
the/DT
200/CD
bp/NN
and/CC
1,500/CD
bp/NN
regions/NNS
upstream/RB
of/IN
the/DT
transcription/NN
start/NN
site/NN
(/(
TSS/NN
)/)
,/,
respectively/RB
./.
====================
We/PRP
also/RB
categorized/VBD
CpG/NN
sites/NNS
as/IN
follows/VBZ
:/:
CGIs/NNS
(/(
i.e./FW
,/,
those/DT
belonging/VBG
to/TO
CGIs/NNS
)/)
,/,
CGI/NNP
shore/RB
and/CC
shelf/PRP
(/(
i.e./FW
,/,
those/DT
located/JJ
in/IN
the/DT
</JJR
2/CD
kb/NN
flanking/JJ
a/DT
CGI/JJ
and/CC
the/DT
</JJR
2/CD
kb/NN
flanking/JJ
outward/RB
from/IN
a/DT
CpG/NN
shore/RB
,/,
respectively/RB
)/)
,/,
and/CC
‘/FW
other./JJ
’/NNP
North/DT
(/(
N/NN
)/)
and/CC
south/IN
(/(
S/NN
)/)
indicate/VBP
upstream/RB
and/CC
downstream/RB
of/IN
the/DT
CGI/NN
,/,
respectively/RB
./.
====================
Fig/NN
./.
====================
2A/NN
and/CC
2B/NN
show/VBP
the/DT
number/NN
of/IN
hypermethylated/JJ
and/CC
hypomethylated/VBN
CpG/NN
sites/NNS
,/,
as/IN
distinguished/VBN
by/IN
M-values/NNS
,/,
in/IN
six/CD
gene-based/VBN
and/CC
five/CD
CGI-based/JJ
CpG/NN
categories/NNS
./.
====================
We/PRP
calculated/VBD
the/DT
ratio/NN
of/IN
hypermethylated/JJ
to/TO
hypomethylated/VBN
CpG/NN
sites/NNS
,/,
which/WDT
was/VBD
defined/VBN
as/IN
the/DT
number/NN
of/IN
hypermethylated/JJ
CpG/NN
sites/NNS
divided/VBN
by/IN
the/DT
number/NN
of/IN
hypomethylated/JJ
CpG/NN
sites/NNS
(/(
Supplementary/JJ
Fig/NN
./.
====================
1/CD
)/)
./.
====================
It/PRP
should/MD
be/VB
noted/VBN
that/IN
the/DT
ratio/NN
of/IN
hypermethylated/JJ
to/TO
hypomethylated/VBN
CpG/NN
sties/NNS
varied/VBD
markedly/RB
in/IN
all/DT
individuals/NNS
with/IN
respect/NN
to/TO
the/DT
genomic/JJ
contexts/NNS
,/,
i.e./FW
,/,
the/DT
previously/RB
described/VBN
gene-based/VBN
(/(
0.20–5.54/CD
)/)
and/CC
CGI-based/JJ
(/(
0.23–8.66/CD
)/)
regional/JJ
categories/NNS
./.
====================
The/DT
genomic/JJ
regions/NNS
near/JJ
TSSs/NNS
,/,
including/VBG
the/DT
5′/JJ
UTR/NN
,/,
first/JJ
exon/NN
,/,
and/CC
TSS200/NN
,/,
were/VBD
mainly/RB
dominated/JJ
by/IN
hypomethylated/VBN
CpG/NN
sites/NNS
(/(
the/DT
ratios/NNS
were/VBD
0.51/CD
,/,
0.24/CD
,/,
and/CC
0.20/CD
,/,
respectively/RB
)/)
./.
====================
By/IN
contrast/NN
,/,
the/DT
CpG/NN
sites/NNS
at/IN
the/DT
gene/NN
body/NN
and/CC
3′/CD
UTR/NN
regions/NNS
were/VBD
usually/RB
hypermethylated/VBN
(/(
the/DT
ratios/NNS
were/VBD
2.47/CD
and/CC
5.54/CD
,/,
respectively/RB
)/)
./.
====================
Moreover/RB
,/,
CGIs/NNS
were/VBD
usually/RB
hypomethylated/VBN
(/(
the/DT
ratio/NN
was/VBD
0.23/CD
)/)
,/,
but/CC
the/DT
5′/NN
and/CC
3′/CD
CGI/NN
shelf/PRP
regions/NNS
were/VBD
hypermethylated/VBN
(/(
the/DT
ratios/NNS
were/VBD
7.87/CD
and/CC
8.66/CD
,/,
respectively/RB
)/)
./.
====================
The/DT
observed/VBN
overall/JJ
pattern/NN
of/IN
DNA/NN
methylation/NN
with/IN
respect/NN
to/TO
nearby/JJ
genes/NNS
or/CC
CGIs/NNS
agrees/NNS
well/RB
with/IN
previous/JJ
reports/NNS
:/:
CpG/NN
sites/NNS
at/IN
promoters/NNS
with/IN
active/JJ
transcription/NN
have/VBP
less/RBR
DNA/NN
methylation/NN
compared/VBN
to/TO
downstream/JJ
compartments/NNS
such/JJ
as/IN
the/DT
gene/NN
body/NN
,/,
and/CC
CpG/NN
sites/NNS
at/IN
CGIs/NNS
are/VBP
relatively/RB
free/JJ
from/IN
methylation/NN
./.
====================
The/DT
genomic/JJ
and/CC
epigenomic/JJ
landscape/NN
of/IN
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
in/IN
obesity/NN
====================
We/PRP
next/RB
identified/VBD
the/DT
CpG/NN
sites/NNS
differentially/RB
methylated/VBN
between/IN
obese/DT
and/CC
control/NN
individuals/NNS
./.
====================
A/DT
total/JJ
of/IN
6,041/CD
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
were/VBD
identified/VBN
to/TO
have/VB
a/DT
significance/NN
level/NN
of/IN
p/NN
</JJR
0.001/CD
./.
====================
The/DT
false/JJ
discovery/NN
rate/NN
(/(
FDR/NN
)/)
was/VBD
0.08/CD
when/WRB
the/DT
Benjamini-Hochberg/NN
method/NN
was/VBD
applied/VBN
to/TO
adjust/VB
the/DT
p-values/NNS
./.
====================
Supplementary/JJ
Fig/NN
./.
====================
2/CD
shows/VBZ
a/DT
Manhattan/JJ
plot/NN
for/IN
the/DT
log-transformed/JJ
significance/NN
levels/NNS
of/IN
all/DT
CpG/NN
sites/NNS
investigated/VBD
./.
====================
Fig/NN
./.
====================
3A/NN
shows/VBZ
an/DT
uneven/JJ
distribution/NN
of/IN
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
with/IN
respect/NN
to/TO
the/DT
six/CD
gene-based/VBN
CpG/NN
categories/NNS
./.
====================
The/DT
over-/JJ
and/CC
under-representation/NN
of/IN
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
was/VBD
observed/VBN
in/IN
gene/NN
body/NN
,/,
TSS200/CD
,/,
and/CC
TSS1500/CD
regions/NNS
(/(
p/NN
=/JJ
4.6/CD
×/CD
10−50/CD
,/,
p/NN
=/JJ
4.33/CD
×/CD
10−12/CD
,/,
and/CC
p/NN
=/JJ
4.33/CD
×/CD
10−19/CD
,/,
respectively/RB
)/)
./.
====================
When/WRB
the/DT
genomic/JJ
context/NN
of/IN
CGIs/NNS
was/VBD
taken/VBN
into/IN
account/VBP
(/(
Fig/NN
./.
====================
3B/NN
)/)
,/,
a/DT
relative/JJ
deficit/NN
of/IN
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
in/IN
the/DT
nearby/JJ
TSS/NN
regions/NNS
was/VBD
observed/VBN
in/IN
CGIs/NNS
,/,
while/IN
the/DT
enrichment/JJ
of/IN
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
in/IN
the/DT
gene/NN
body/NN
was/VBD
observed/VBN
at/IN
regions/NNS
distant/JJ
from/IN
CGI/NN
(/(
i.e./FW
,/,
CGI/NNP
shelves/VBZ
and/CC
others/NNS
)/)
./.
====================
Next/RB
,/,
we/PRP
divided/VBD
the/DT
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
into/IN
hypermethylated/JJ
and/CC
hypomethylated/VBN
sites/NNS
in/IN
obese/DT
children/NN
./.
====================
We/PRP
annotated/VBD
them/PRP
as/IN
‘/CD
obese-hypermethylated/VBN
and/CC
obese-hypomethylated/VBN
CpGs/NNS
’/CD
to/TO
distinguish/VB
them/PRP
from/IN
the/DT
hypomethylated/hypermethylated/JJ
CpG/NN
sites/NNS
identified/VBD
in/IN
individual/JJ
M-value/NN
profiles/NNS
./.
====================
We/PRP
observed/VBD
a/DT
dominance/NN
of/IN
obese-hypomethylated/VBN
CpG/NN
sites/NNS
(/(
79.1/CD
%/NN
;/:
4,779/CD
sites/NNS
)/)
over/IN
obese-hypermethylated/VBN
CpG/NN
sites/NNS
among/IN
all/DT
of/IN
the/DT
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
(/(
Fig/NN
./.
====================
3C/NN
)/)
./.
====================
We/PRP
then/RB
investigated/VBD
the/DT
relative/JJ
ratio/NN
of/IN
obese-hypermethylated/VBN
to/TO
obese-hypomethylated/VBN
CpG/NN
sites/NNS
in/IN
gene-based/VBN
and/CC
CGI-based/JJ
regional/JJ
categories/NNS
(/(
Fig/NN
./.
====================
3D/NN
and/CC
3E/NN
)/)
./.
====================
The/DT
majority/NN
of/IN
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
in/IN
the/DT
gene/NN
body/NN
and/CC
3′/CD
UTR/NN
regions/NNS
were/VBD
obese-hypomethylated/VBN
CpG/NN
sites/NNS
(/(
the/DT
ratios/NNS
of/IN
obese-hypermethylated/obese-hypomethylated/VBN
CpG/NN
sites/NNS
in/IN
these/DT
regions/NNS
were/VBD
0.13/CD
and/CC
0.03/CD
,/,
respectively/RB
)/)
(/(
Fig/NN
./.
====================
3D/NN
)/)
./.
====================
On/IN
the/DT
other/JJ
hand/NN
,/,
the/DT
differentially/RB
methylated/VBN
sites/NNS
in/IN
the/DT
genomic/JJ
regions/NNS
near/JJ
the/DT
TSS/NN
,/,
such/JJ
as/IN
the/DT
TSS200/NN
and/CC
first/JJ
exon/NN
regions/NNS
,/,
were/VBD
mainly/RB
composed/VBN
of/IN
obese-hypermethylated/VBN
CpG/NN
sites/NNS
(/(
the/DT
ratios/NNS
were/VBD
2.14/CD
and/CC
1.52/CD
,/,
respectively/RB
)/)
(/(
Fig/NN
./.
====================
3D/NN
)/)
./.
====================
A/DT
dominance/NN
of/IN
obese-hypermethylated/VBN
CpG/NN
sites/NNS
was/VBD
also/RB
noted/VBN
in/IN
CGI/NN
regions/NNS
(/(
the/DT
ratio/NN
was/VBD
1.64/CD
)/)
,/,
whereas/IN
CpG/NN
sites/NNS
in/IN
CGI-shelf/NN
regions/NNS
were/VBD
largely/RB
obese-hypomethylated/VBN
(/(
the/DT
ratio/NN
was/VBD
0.02/CD
)/)
(/(
Fig/NN
./.
====================
3E/CD
)/)
./.
====================
Of/IN
note/NN
,/,
70.8/CD
%/NN
of/IN
obese-hypermethylated/VBN
CpG/NN
sites/NNS
were/VBD
found/VBN
in/IN
CGIs/NNS
./.
====================
Next/RB
,/,
we/PRP
categorized/VBD
the/DT
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
according/VBG
to/TO
15/CD
different/JJ
chromatin/NN
states/NNS
,/,
as/IN
described/VBN
in/IN
the/DT
ChromHMM/NN
software/JJ
[/(
16/CD
]/)
./.
====================
Given/IN
the/DT
tissue-specific/JJ
epigenetic/JJ
configurations/NNS
,/,
we/PRP
elected/VBD
to/TO
use/VB
the/DT
annotation/NN
dataset/NN
of/IN
lymphoid/JJ
origin/NN
(/(
from/IN
the/DT
GM12878/NN
lymphoblastoid/JJ
cell/NN
line/NN
)/)
as/IN
the/DT
profile/NN
that/IN
best/JJS
matched/VBN
ours/VBZ
./.
====================
We/PRP
first/RB
observed/VBN
that/IN
the/DT
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
were/VBD
overrepresented/VBN
mainly/RB
on/IN
transcribed/VBN
regions/NNS
(/(
Fig/NN
./.
====================
4A/CD
)/)
./.
====================
The/DT
p-values/NNS
were/VBD
2.91/CD
×/CD
10−3/CD
,/,
1.63/CD
×/CD
10−11/CD
,/,
and/CC
8.31/CD
×/CD
10−16/CD
for/IN
the/DT
9_Txn_Transition/NN
(/(
transcription/NN
transition/NN
)/)
,/,
10_Txn_elongation/NN
(/(
transcription/NN
elongation/NN
)/)
and/CC
11_Weak_Txn/JJ
(/(
weak/JJ
transcription/NN
)/)
regions/NNS
,/,
respectively/RB
(/(
Fisher/RB
's/POS
exact/JJ
test/NN
)/)
./.
====================
It/PRP
was/VBD
also/RB
observed/VBN
that/IN
promoter/NN
and/CC
enhancer/NN
regions/NNS
were/VBD
largely/RB
depleted/VBN
of/IN
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
./.
====================
In/IN
particular/JJ
,/,
all/DT
promoter-related/JJ
states/NNS
represented/VBN
in/IN
the/DT
first/JJ
three/CD
state/NN
categories/NNS
(/(
1_Active_Promoter/NN
,/,
2_Weak_Promoter/RBR
,/,
and/CC
3_Poised_Promoter/NN
)/)
showed/VBD
underrepresentation/NN
for/IN
the/DT
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
(/(
Fig/NN
./.
====================
4A/CD
)/)
./.
====================
That/DT
is/VBZ
,/,
as/IN
we/PRP
observed/VBD
in/IN
the/DT
genomic/JJ
regional/JJ
abundance/NN
analysis/NN
,/,
the/DT
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
were/VBD
mainly/RB
found/VBN
at/IN
the/DT
genomic/JJ
regions/NNS
marked/JJ
for/IN
active/JJ
transcription/NN
./.
====================
When/WRB
the/DT
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
were/VBD
categorized/VBN
into/IN
obese-hypermethylated/VBN
and/CC
obese-hypomethylated/VBN
CpG/NN
sites/NNS
(/(
Fig/NN
./.
====================
4B/NN
)/)
,/,
a/DT
majority/NN
of/IN
the/DT
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
in/IN
transcribed/VBN
and/CC
promoter-related/VBD
regions/NNS
were/VBD
obese-hyper-/VBN
and/CC
obese-hypomethylated/VBN
CpG/NN
sites/NNS
,/,
respectively/RB
./.
====================
For/IN
instance/NN
,/,
96.6/CD
%/NN
of/IN
CpG/NN
sites/NNS
in/IN
active/JJ
promoter/NN
regions/NNS
,/,
as/IN
well/RB
as/IN
95.7/CD
%/NN
and/CC
62.4/CD
%/NN
of/IN
CpG/NN
sites/NNS
at/IN
poised/VBN
promoter/NN
and/CC
weak/JJ
promoter/NN
,/,
respectively/RB
,/,
were/VBD
obese-hypermethylated/VBN
CpG/NN
sites/NNS
./.
====================
In/IN
contrast/NN
to/TO
the/DT
promoter/NN
regions/NNS
,/,
95.7/CD
%/NN
of/IN
the/DT
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
in/IN
transcriptional/JJ
regions/NNS
,/,
annotated/JJ
in/IN
ChromHMM/NN
as/IN
transcriptional/JJ
transition/NN
,/,
elongation/NN
,/,
or/CC
weak/JJ
transcription/NN
,/,
showed/VBD
lower/JJR
DNA/NN
methylation/NN
levels/NNS
in/IN
obese/DT
children/NN
./.
====================
Functional/JJ
relationships/NNS
between/IN
DNA/NN
methylation/NN
markers/NNS
and/CC
obesity/NN
====================
We/PRP
next/RB
identified/VBD
21/CD
genes/NNS
with/IN
significant/JJ
enrichment/JJ
of/IN
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
in/IN
the/DT
obese/JJ
children/NN
(/(
Fisher/RB
's/POS
exact/JJ
test/NN
;/:
p/NN
</JJR
0.001/CD
)/)
(/(
Supplementary/JJ
Fig/NN
./.
====================
3/CD
)/)
./.
====================
The/DT
CpG/NN
sites/NNS
in/IN
the/DT
enriched/JJ
genes/NNS
were/VBD
mainly/RB
obese-hypomethylated/VBN
and/CC
located/JJ
mostly/RB
in/IN
the/DT
gene/NN
body/NN
region/NN
,/,
which/WDT
was/VBD
expected/VBN
given/VBN
the/DT
overall/JJ
distribution/NN
of/IN
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
./.
====================
We/PRP
further/RB
investigated/VBD
the/DT
extent/NN
of/IN
differential/JJ
expression/NN
of/IN
these/DT
genes/NNS
between/IN
the/DT
obese/JJ
and/CC
control/NN
individuals/NNS
using/VBG
the/DT
same/JJ
statistical/JJ
method/NN
as/IN
was/VBD
used/VBN
for/IN
the/DT
identification/NN
of/IN
the/DT
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
(/(
R/NN
limma/NN
package/NN
;/:
see/VB
Methods/NNS
)/)
./.
====================
However/RB
,/,
none/NN
of/IN
these/DT
21/CD
genes/NNS
showed/VBD
significantly/RB
differential/JJ
expression/NN
(/(
unadjusted/JJ
p/NN
</JJR
0.001/CD
)/)
./.
====================
Supplementary/JJ
Table/JJ
1/CD
lists/NNS
the/DT
significance/NN
level/NN
for/IN
the/DT
differential/JJ
expression/NN
of/IN
18/CD
of/IN
the/DT
21/CD
genes/NNS
;/:
excluded/VBN
are/VBP
MIR1185-2/NN
,/,
FLJ39609/NN
,/,
and/CC
CELA2A/NN
,/,
with/IN
no/DT
expression/NN
values/NNS
available/JJ
./.
====================
Although/IN
one/CD
gene/NN
,/,
ZNF154/NN
,/,
with/IN
obese-hypermethylation/NN
at/IN
TSS200/CD
showed/VBD
a/DT
slight/JJ
downregulation/NN
in/IN
expression/NN
(/(
unadjusted/JJ
p/NN
</JJR
0.05/CD
)/)
,/,
most/JJS
cases/NNS
showed/VBD
no/DT
clear/JJ
relationship/NN
between/IN
gene/NN
expression/NN
and/CC
CpG/NN
methylation/NN
./.
====================
One/CD
possible/JJ
explanation/NN
for/IN
this/DT
observation/NN
is/VBZ
that/IN
the/DT
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
at/IN
the/DT
enriched/JJ
genes/NNS
were/VBD
mainly/RB
located/JJ
in/IN
the/DT
gene/NN
body/NN
,/,
the/DT
methylation/NN
of/IN
which/WDT
is/VBZ
not/RB
always/RB
associated/VBN
with/IN
the/DT
expression/NN
of/IN
the/DT
genes/NNS
,/,
in/IN
contrast/NN
to/TO
the/DT
methylation/NN
of/IN
regulatory/JJ
regions/NNS
such/JJ
as/IN
gene/NN
promoters/NNS
./.
====================
In/IN
this/DT
exploratory/JJ
study/NN
,/,
we/PRP
focused/VBD
on/IN
the/DT
identification/NN
of/IN
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
that/IN
may/MD
be/VB
able/JJ
to/TO
distinguish/VB
young/JJ
obese/DT
individuals/NNS
from/IN
young/JJ
normal/JJ
individuals/NNS
;/:
the/DT
association/NN
between/IN
gene/NN
expression/NN
and/CC
CpG/NN
methylation/NN
,/,
as/IN
well/RB
as/IN
their/PRP$
early/JJ
diagnostic/JJ
potential/JJ
,/,
requires/VBZ
further/RBR
investigation/NN
./.
====================
Lastly/RB
,/,
we/PRP
investigated/VBD
the/DT
potential/JJ
relationship/NN
between/IN
the/DT
observed/VBN
genes/NNS
with/IN
significant/JJ
enrichment/JJ
of/IN
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
and/CC
the/DT
pathogenesis/NN
of/IN
obesity/NN
based/VBN
on/IN
previously/RB
published/VBN
studies/NNS
./.
====================
Among/IN
the/DT
genes/NNS
with/IN
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
,/,
ZNF154/NN
encodes/VBZ
a/DT
member/NN
of/IN
the/DT
zinc/NN
finger/NN
protein/NN
family/NN
,/,
which/WDT
are/VBP
transcriptional/JJ
regulators/NNS
of/IN
adipogenesis/NN
[/(
17/CD
]/)
./.
====================
POLR3E/NN
encodes/VBZ
DNA-directed/JJ
RNA/NN
polymerase/NN
III/CD
subunit/NN
RPC5/NN
,/,
and/CC
it/PRP
is/VBZ
known/VBN
that/IN
the/DT
loss/NN
of/IN
MAF/NN
,/,
which/WDT
is/VBZ
a/DT
repressor/NN
of/IN
RNA/NN
polymerase/NN
III/CD
,/,
affects/VBZ
resistance/NN
to/TO
obesity/NN
[/(
18/CD
]/)
./.
====================
Although/IN
the/DT
direct/JJ
effects/NNS
of/IN
SDK1/NN
,/,
which/WDT
encodes/VBZ
sidekick/JJ
cell/NN
adhesion/NN
molecule/NN
1/CD
,/,
on/IN
obesity/NN
are/VBP
unknown/JJ
,/,
some/DT
studies/NNS
have/VBP
investigated/VBN
the/DT
relationships/NNS
between/IN
cellular/JJ
adhesion/NN
molecules/NNS
and/CC
obesity/NN
[/(
19/CD
]/)
./.
====================
KIAA0146/CD
is/VBZ
a/DT
scaffolding/JJ
protein/NN
involved/VBN
in/IN
DNA/NN
repair/NN
,/,
and/CC
it/PRP
has/VBZ
been/VBN
reported/VBN
that/IN
DNA/NN
damage/NN
or/CC
DNA/NN
repair/NN
deficiency/NN
may/MD
be/VB
associated/VBN
with/IN
obesity/NN
[/(
20/CD
]/)
./.
====================
GPR125/NN
encodes/VBZ
a/DT
membrane/NN
protein/NN
that/WDT
belongs/VBZ
to/TO
the/DT
G/NN
protein-coupled/JJ
receptor/NN
superfamily/NN
./.
====================
Previous/JJ
studies/NNS
have/VBP
revealed/VBN
that/IN
G/NN
protein-coupled/JJ
receptors/NNS
may/MD
serve/VB
as/IN
therapeutic/JJ
targets/NNS
for/IN
obesity/NN
and/CC
type/NN
2/CD
diabetes/NNS
[/(
21/CD
]/)
./.
====================
CAPS2/NN
encodes/VBZ
a/DT
calcium-binding/JJ
protein/NN
and/CC
may/MD
function/VB
in/IN
the/DT
regulation/NN
of/IN
the/DT
secretion/NN
of/IN
insulin/NN
[/(
22/CD
]/)
./.
====================
RNF213/NN
encodes/VBZ
a/DT
ring/NN
finger/NN
protein/NN
,/,
which/WDT
is/VBZ
a/DT
specialized/VBN
type/NN
of/IN
zinc/NN
finger/NN
protein/NN
./.
====================
A/DT
study/NN
found/VBD
the/DT
depletion/NN
of/IN
RNF213/NN
increased/VBD
glucose/NN
tolerance/NN
in/IN
mice/NNS
[/(
23/CD
]/)
./.
====================
CELA2A/NN
belongs/VBZ
to/TO
the/DT
chymotrypsin-like/JJ
elastase/NN
family/NN
,/,
and/CC
a/DT
relationship/NN
between/IN
neutrophil/NN
elastase/NN
and/CC
insulin/NN
resistance/NN
has/VBZ
been/VBN
previously/RB
reported/VBD
[/(
24/CD
]/)
./.
====================
Given/IN
that/DT
some/DT
of/IN
the/DT
genes/NNS
harbor/VBP
more/RBR
frequent/JJ
than/IN
expected/VBN
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
have/VBP
been/VBN
previously/RB
implicated/VBN
in/IN
the/DT
metabolic/JJ
disorders/NNS
,/,
further/RB
investigation/NN
of/IN
these/DT
genes/NNS
and/CC
their/PRP$
role/NN
in/IN
childhood/NN
obesity/NN
is/VBZ
required/VBN
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
carried/VBD
out/RP
the/DT
microarray-based/VBN
profiling/VBG
of/IN
DNA/NN
methylation/NN
and/CC
gene/NN
expression/NN
in/IN
peripheral/JJ
white/JJ
blood/NN
cells/NNS
obtained/VBN
from/IN
obese/DT
and/CC
normal/JJ
children/NN
./.
====================
We/PRP
investigated/VBD
whether/IN
the/DT
DNA/NN
methylation/NN
or/CC
gene/NN
expression/NN
profiles/NNS
(/(
1/LS
)/)
are/VBP
distinct/JJ
between/IN
the/DT
young/JJ
obese/DT
individuals/NNS
and/CC
controls/VBZ
,/,
(/(
2/CD
)/)
show/VBP
unique/JJ
enrichment/JJ
patterns/NNS
of/IN
hyper-vs-hypomethylated/JJ
CpG/NN
sites/NNS
with/IN
respect/NN
to/TO
nearby/JJ
genes/NNS
or/CC
CGIs/NNS
,/,
and/CC
(/(
3/LS
)/)
whether/IN
such/JJ
enrichment/JJ
patterns/NNS
are/VBP
also/RB
observed/VBN
for/IN
CpG/NN
sites/NNS
that/IN
are/VBP
differentially/RB
methylated/VBN
between/IN
young/JJ
obese/DT
individuals/NNS
and/CC
controls/VBZ
./.
====================
We/PRP
first/RB
examined/VBN
whether/IN
the/DT
gene/NN
expression/NN
or/CC
DNA/NN
methylation/NN
profiles/NNS
could/MD
be/VB
used/VBN
to/TO
distinguish/VB
the/DT
obese/JJ
individuals/NNS
from/IN
the/DT
normal/JJ
control/JJ
individuals/NNS
./.
====================
Unsupervised/JJ
clustering/NN
of/IN
the/DT
DNA/NN
methylation/NN
profiles/NNS
segregated/VBD
the/DT
obese/JJ
individuals/NNS
from/IN
controls/NNS
,/,
suggesting/VBG
that/IN
the/DT
young/JJ
obese/DT
individuals/NNS
harbor/VBP
epigenetic/JJ
marks/NNS
in/IN
their/PRP$
peripheral/JJ
blood/NN
cells/NNS
that/WDT
are/VBP
distinct/JJ
from/IN
those/DT
of/IN
normal/JJ
controls/NNS
./.
====================
For/IN
marker/NN
selection/NN
,/,
we/PRP
further/RB
performed/VBN
leave-one-out-cross-validation/NN
,/,
k-nearest/JJS
neighborhood/NN
(/(
k-NN/NN
)/)
method-based/VBN
marker/NN
selection/NN
,/,
and/CC
predictive/JJ
modeling/VBG
./.
====================
For/IN
12/CD
rounds/NNS
of/IN
iterations/NNS
,/,
we/PRP
selected/VBD
the/DT
top/NN
100/CD
differentially/RB
methylated/VBN
sites/NNS
using/VBG
the/DT
empirical/JJ
Bayes/NNS
approach/NN
and/CC
predicted/VBN
the/DT
phenotypes/NNS
of/IN
the/DT
selected/VBN
cases/NNS
./.
====================
However/RB
,/,
we/PRP
did/VBD
not/RB
achieve/VB
a/DT
good/JJ
classification/NN
accuracy/NN
using/VBG
jackknife/NN
approaches/NNS
for/IN
cross-validation/NN
for/IN
the/DT
gene/NN
expression/NN
datasets/NNS
or/CC
the/DT
DNA/NN
methylation/NN
profiles/NNS
./.
====================
The/DT
results/NNS
imply/VBP
that/IN
obesity/NN
can/MD
not/RB
be/VB
completely/RB
predicted/VBN
by/IN
a/DT
small/JJ
number/NN
of/IN
candidate/NN
biomarkers/NNS
./.
====================
Instead/RB
,/,
our/PRP$
genome-wide/NN
analyses/NNS
showed/VBD
that/IN
there/EX
are/VBP
aberrant/JJ
DNA/NN
methylation/NN
patterns/NNS
in/IN
obese/DT
children/NN
compared/VBN
to/TO
normal/JJ
children/NN
./.
====================
Abnormal/JJ
DNA/NN
methylation/NN
patterns/NNS
have/VBP
been/VBN
observed/VBN
in/IN
wide/JJ
variety/NN
of/IN
human/JJ
diseases/NNS
./.
====================
Certain/JJ
studies/NNS
suggest/VBP
that/IN
abnormal/JJ
DNA/NN
methylation/NN
patterns/NNS
in/IN
some/DT
of/IN
these/DT
diseases/NNS
include/VBP
the/DT
loss/NN
of/IN
DNA/NN
methylation/NN
on/IN
gene/NN
bodies/NNS
and/CC
the/DT
gain/NN
of/IN
DNA/NN
methylation/NN
on/IN
gene/NN
promoter/NN
CGIs/NNS
,/,
which/WDT
is/VBZ
by/IN
and/CC
large/JJ
the/DT
opposite/JJ
of/IN
the/DT
normal/JJ
physiological/JJ
methylation/NN
pattern/NN
found/VBN
in/IN
the/DT
human/JJ
genome/NN
[/(
2526/CD
]/)
./.
====================
Our/PRP$
analyses/NNS
revealed/VBD
that/IN
the/DT
majority/NN
of/IN
the/DT
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
are/VBP
those/DT
with/IN
relative/JJ
hypomethylation/NN
in/IN
obese/DT
children/NN
./.
====================
Such/JJ
obese-hypomethylated/VBN
CpG/NN
sites/NNS
were/VBD
overrepresented/VBN
in/IN
gene/NN
body/NN
regions/NNS
and/CC
represented/VBD
one/CD
of/IN
the/DT
major/JJ
epigenetic/JJ
alterations/NNS
in/IN
the/DT
blood/NN
cells/NNS
of/IN
young/JJ
obese/DT
individuals/NNS
./.
====================
In/IN
addition/NN
,/,
our/PRP$
results/NNS
implied/VBD
that/DT
regulatory/JJ
CpG/NN
sites/NNS
near/JJ
TSS/NN
in/IN
obese/DT
individuals/NNS
tended/VBD
to/TO
be/VB
relatively/RB
hypermethylated/JJ
compared/VBN
to/TO
controls/NNS
./.
====================
This/DT
observation/NN
was/VBD
further/RBR
validated/VBN
by/IN
the/DT
evaluation/NN
of/IN
chromatin/NN
status/NN
using/VBG
chromHMM/JJ
data/NNS
,/,
where/WRB
the/DT
combined/JJ
analyses/NNS
showed/VBD
relative/JJ
hypermethylation/NN
of/IN
regulatory/JJ
regions/NNS
(/(
active/JJ
,/,
weak/JJ
,/,
and/CC
poised/VBD
promoters/NNS
)/)
but/CC
hypomethylation/NN
of/IN
transcribed/VBN
regions/NNS
(/(
those/DT
annotated/VBN
as/IN
transcription/NN
transition/NN
,/,
elongation/NN
,/,
or/CC
weak/JJ
transcription/NN
)/)
in/IN
obese/DT
individuals/NNS
compared/VBN
to/TO
controls/NNS
./.
====================
When/WRB
we/PRP
searched/VBD
for/IN
differentially/RB
expressed/VBN
genes/NNS
using/VBG
the/DT
same/JJ
criteria/NNS
as/IN
those/DT
used/VBN
for/IN
the/DT
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
,/,
a/DT
relatively/RB
small/JJ
number/NN
of/IN
genes/NNS
with/IN
a/DT
p/NN
</JJR
0.001/CD
and/CC
a/DT
corresponding/JJ
FDR/NN
of/IN
0.91/CD
were/VBD
identified/VBN
(/(
Supplementary/JJ
Table/JJ
2/CD
)/)
./.
====================
Given/IN
the/DT
fact/NN
that/IN
the/DT
expression-based/VBN
k-NN/NN
predictive/JJ
model/NN
failed/VBD
to/TO
identify/VB
obese/DT
individuals/NNS
,/,
the/DT
gene/NN
expression/NN
profiles/NNS
may/MD
not/RB
serve/VB
as/IN
appropriate/JJ
biomarkers/NNS
of/IN
obesity/NN
in/IN
youth/JJ
./.
====================
However/RB
,/,
we/PRP
found/VBD
that/IN
some/DT
of/IN
the/DT
top-ranked/JJ
genes/NNS
were/VBD
also/RB
related/JJ
to/TO
epigenetic/JJ
regulation/NN
./.
====================
For/IN
example/NN
,/,
histone/NN
deacetylases/NNS
(/(
HDACs/NNS
)/)
are/VBP
related/JJ
to/TO
insulin/NN
sensitivity/NN
,/,
and/CC
HDAC/NN
inhibition/NN
can/MD
be/VB
a/DT
treatment/NN
for/IN
diabetes/NNS
./.
====================
Moreover/RB
,/,
since/IN
HDAC2/NN
can/MD
directly/RB
bind/VBP
to/TO
DNMT1/NN
,/,
a/DT
widely/RB
expressed/VBN
DNA/NN
methyltransferase/NN
that/DT
plays/VBZ
a/DT
role/NN
in/IN
maintaining/VBG
DNA/NN
methylation/NN
patterns/NNS
[/(
27/CD
]/)
,/,
the/DT
change/NN
in/IN
HDAC2/NN
expression/NN
may/MD
be/VB
related/JJ
to/TO
the/DT
aberrant/JJ
DNA/NN
methylation/NN
patterns/NNS
we/PRP
observed/VBD
in/IN
obese/DT
individuals/NNS
./.
====================
Our/PRP$
pilot/NN
study/NN
provides/VBZ
a/DT
line/NN
of/IN
evidence/NN
for/IN
the/DT
importance/NN
of/IN
epigenomic/JJ
characteristics/NNS
in/IN
investigating/VBG
childhood/NN
obesity/NN
and/CC
also/RB
the/DT
potential/JJ
utility/NN
of/IN
such/JJ
markers/NNS
for/IN
the/DT
early/JJ
diagnosis/NN
of/IN
obese/DT
children/NN
./.
====================
Blood/NN
represents/VBZ
a/DT
mixture/NN
of/IN
multiple/JJ
types/NNS
of/IN
cells/NNS
,/,
the/DT
composition/NN
of/IN
which/WDT
has/VBZ
been/VBN
reported/VBN
to/TO
vary/VB
between/IN
obese/DT
and/CC
lean/JJ
individuals/NNS
./.
====================
For/IN
example/NN
,/,
through/IN
analysis/NN
of/IN
blood/NN
cell/NN
fractions/NNS
,/,
a/DT
study/NN
verified/VBD
that/DT
DNA/NN
methylation/NN
in/IN
B/NN
cell/NN
and/CC
natural/JJ
killer/NN
lymphocytes/NNS
is/VBZ
altered/JJ
in/IN
obese/DT
subjects/NNS
[/(
28/CD
]/)
;/:
other/JJ
studies/NNS
have/VBP
reported/VBN
similar/JJ
results/NNS
[/(
2930/CD
]/)
./.
====================
The/DT
cellular/JJ
heterogeneity/NN
and/CC
the/DT
differing/VBG
number/NN
of/IN
blood/NN
cell/NN
counts/NNS
between/IN
individuals/NNS
could/MD
affects/VBZ
DNA/NN
methylation/NN
analysis/NN
[/(
31/CD
]/)
./.
====================
Thus/RB
,/,
further/RB
investigation/NN
of/IN
the/DT
DNA/NN
methylation/NN
profiles/NNS
,/,
with/IN
consideration/NN
of/IN
the/DT
cell/NN
heterogeneity/NN
in/IN
blood/NN
,/,
may/MD
lead/VB
to/TO
a/DT
clearer/JJ
understanding/NN
of/IN
the/DT
epigenomic/JJ
differences/NNS
in/IN
obese/DT
children/NN
./.
====================
To/TO
date/NN
,/,
a/DT
number/NN
of/IN
genome-wide/NN
studies/NNS
have/VBP
presented/VBN
associations/NNS
between/IN
inherited/VBN
germline/NN
variants/NNS
and/CC
metabolic/JJ
disorders/NNS
,/,
such/JJ
as/IN
type/NN
2/CD
diabetes/NNS
and/CC
obesity/NN
./.
====================
However/RB
,/,
a/DT
majority/NN
of/IN
patients/NNS
still/RB
lack/VBP
clarity/NN
on/IN
the/DT
causal/JJ
,/,
heritable/JJ
factors/NNS
underlying/VBG
their/PRP$
disease/NN
,/,
suggesting/VBG
that/IN
there/EX
are/VBP
still/RB
many/JJ
limitations/NNS
to/TO
overcome/VB
for/IN
these/DT
germline/NN
markers/NNS
to/TO
be/VB
practically/RB
used/VBN
for/IN
diagnostic/JJ
and/CC
prognostic/JJ
purposes/NNS
./.
====================
Measuring/VBG
the/DT
alterations/NNS
in/IN
DNA/NN
methylation/NN
profiles/NNS
detectable/JJ
in/IN
blood/NN
as/IN
a/DT
minimally/RB
invasive/JJ
biological/JJ
resource/NN
may/MD
be/VB
useful/JJ
not/RB
only/RB
in/IN
understanding/VBG
the/DT
epigenomic/JJ
effects/NNS
on/IN
obesity/NN
,/,
but/CC
also/RB
in/IN
providing/VBG
critical/JJ
insight/NN
and/CC
clinical/JJ
applications/NNS
for/IN
the/DT
early/JJ
detection/NN
of/IN
obesity/NN
./.
====================
However/RB
,/,
our/PRP$
findings/NNS
were/VBD
obtained/VBN
from/IN
a/DT
relatively/RB
small/JJ
cohort/NN
(/(
n/NN
=/JJ
6/CD
)/)
,/,
so/RB
the/DT
statistical/JJ
power/JJR
was/VBD
limited/VBN
./.
====================
Thus/RB
,/,
the/DT
interpretation/NN
of/IN
the/DT
results/NNS
from/IN
our/PRP$
pilot/NN
study/NN
requires/VBZ
caution/NN
./.
====================
Further/RB
investigation/NN
to/TO
ascertain/VB
the/DT
clinical/JJ
impact/NN
of/IN
our/PRP$
results/NNS
is/VBZ
needed/VBN
in/IN
a/DT
larger/JJR
,/,
independent/JJ
cohort/NN
of/IN
young/JJ
obese/DT
individuals/NNS
./.
====================
Additional/JJ
studies/NNS
integrating/VBG
genetic/JJ
and/CC
epigenetic/JJ
information/NN
could/MD
unveil/VB
clues/NNS
that/IN
deepen/VBP
our/PRP$
understanding/NN
of/IN
the/DT
pathogenesis/NN
of/IN
obesity/NN
and/CC
that/IN
help/VBP
to/TO
improve/VB
the/DT
diagnostic/JJ
and/CC
prognostic/JJ
markers/NNS
for/IN
use/NN
in/IN
the/DT
clinic/JJ
./.
====================
Distribution/NN
of/IN
DNA/NN
methylation/NN
profiles/NNS
./.
====================
Hierarchical/JJ
clustering/NN
was/VBD
performed/VBN
using/VBG
the/DT
expression/NN
of/IN
genes/NNS
(/(
A/DT
)/)
and/CC
the/DT
DNA/NN
methylation/NN
patterns/NNS
(/(
B/NN
)/)
in/IN
obese/DT
(/(
Obese/DT
1–6/CD
)/)
and/CC
control/NN
individuals/NNS
(/(
Normal/JJ
1–6/CD
)/)
./.
====================
(/(
C/NN
)/)
The/DT
distribution/NN
of/IN
beta-values/NNS
is/VBZ
shown/VBN
across/IN
12/CD
individuals/NNS
(/(
red/JJ
and/CC
blue/JJ
for/IN
obese/DT
and/CC
control/NN
individuals/NNS
,/,
respectively/RB
)/)
./.
====================
Left/NN
and/CC
right/JJ
insets/NNS
are/VBP
magnified/VBN
as/IN
views/VBZ
of/IN
peaks/NNS
representing/VBG
hypomethylated/VBN
and/CC
hypermethylated/JJ
CpG/NN
sites/NNS
,/,
respectively/RB
./.
====================
(/(
D/NN
)/)
The/DT
distribution/NN
of/IN
M-values/NNS
represented/VBN
in/IN
a/DT
similar/JJ
manner/NN
to/TO
that/DT
shown/VBN
in/IN
panel/NN
C./FW
(/(
E/NN
)/)
Boxplot/NN
of/IN
hypomethylated/JJ
CpG/NN
sites/NNS
shown/VBN
across/IN
12/CD
individuals/NNS
./.
====================
The/DT
cases/NNS
are/VBP
sorted/VBN
in/IN
order/NN
of/IN
the/DT
median/JJ
of/IN
M-values/NNS
./.
====================
(/(
F/NN
)/)
Hypermethylated/JJ
CpG/NN
sites/NNS
are/VBP
represented/VBN
in/IN
a/DT
similar/JJ
manner/NN
to/TO
that/DT
shown/VBN
in/IN
panel/NN
E/NN
./.
====================
Distribution/NN
of/IN
hypermethylated/JJ
and/CC
hypomethylated/VBN
CpG/NN
sites/NNS
with/IN
respect/NN
to/TO
nearby/JJ
genes/NNS
and/CC
CpG/NN
islands/NNS
(/(
CGIs/NNS
)/)
./.
====================
(/(
A/NN
)/)
The/DT
numbers/NNS
of/IN
hypermethylated/JJ
and/CC
hypomethylated/VBN
CpG/NN
sites/NNS
are/VBP
shown/VBN
for/IN
six/CD
gene-based/VBN
CpG/NN
categories/NNS
./.
====================
(/(
B/NN
)/)
CGI-based/JJ
CpG/NN
categories/NNS
are/VBP
represented/VBN
in/IN
a/DT
similar/JJ
manner/NN
to/TO
that/DT
shown/VBN
in/IN
panel/NN
A/NN
./.
====================
The/DT
y-axis/NN
is/VBZ
the/DT
summation/NN
of/IN
the/DT
CpG/NN
sites/NNS
across/IN
all/DT
individuals/NNS
./.
====================
TSS1500/CD
,/,
1,500/CD
bp/NN
regions/NNS
upstream/RB
of/IN
the/DT
transcription/NN
start/NN
site/NN
;/:
TSS200/CD
,/,
200/CD
bp/NN
regions/NNS
upstream/RB
of/IN
the/DT
transcription/NN
start/NN
site/NN
;/:
UTR/NN
,/,
untranslated/JJ
region/NN
;/:
CGI/NNP
,/,
CpG/NN
island/NN
./.
====================
Genomic/JJ
contexts/VBZ
for/IN
the/DT
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
./.
====================
(/(
A/NN
)/)
A/DT
plot/NN
showing/VBG
the/DT
proportions/NNS
of/IN
the/DT
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
across/IN
gene-based/VBN
categories/NNS
./.
====================
The/DT
p-value/JJ
was/VBD
estimated/VBN
using/VBG
Fisher/JJ
's/POS
exact/JJ
tests/NNS
./.
====================
Red/VBN
and/CC
blue/JJ
colors/NNS
represent/VBP
the/DT
relative/JJ
over-/NN
and/CC
under-representation/NN
of/IN
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
in/IN
each/DT
of/IN
the/DT
genomic/JJ
regions/NNS
./.
====================
(/(
B/NN
)/)
Shown/JJ
in/IN
relation/NN
to/TO
the/DT
CpG/NN
islands/NNS
(/(
CGIs/NNS
)/)
in/IN
each/DT
genomic/JJ
region/NN
./.
====================
(/(
C/NN
)/)
The/DT
numbers/NNS
of/IN
obese-hypermethylated/VBN
and/CC
obese-hypomethylated/VBN
CpG/NN
sites/NNS
identified/VBD
from/IN
the/DT
differentially/RB
methylated/VBN
sites/NNS
are/VBP
shown/VBN
./.
====================
(/(
D/NN
)/)
The/DT
proportions/NNS
of/IN
obese-hypermethylated/VBN
and/CC
obese-hypomethylated/VBN
CpG/NN
sites/NNS
are/VBP
shown/VBN
with/IN
respect/NN
to/TO
nearby/JJ
genes/NNS
./.
====================
(/(
E/NN
)/)
The/DT
same/JJ
proportions/NNS
are/VBP
shown/VBN
with/IN
respect/NN
to/TO
CGI-based/JJ
categories/NNS
./.
====================
TSS1500/CD
,/,
1,500/CD
bp/NN
regions/NNS
upstream/RB
of/IN
the/DT
transcription/NN
start/NN
site/NN
;/:
TSS200/CD
,/,
200/CD
bp/NN
regions/NNS
upstream/RB
of/IN
the/DT
transcription/NN
start/NN
site/NN
;/:
UTR/NN
,/,
untranslated/JJ
region/NN
./.
====================
Chromatin/NN
state/NN
enrichment/JJ
at/IN
the/DT
differentially/RB
methylated/VBN
regions/NNS
./.
====================
(/(
A/NN
)/)
The/DT
proportions/NNS
of/IN
chromatin/NN
states/NNS
for/IN
the/DT
differentially/RB
methylated/VBN
CpG/NN
sites/NNS
compared/VBN
to/TO
all/DT
CpG/NN
sites/NNS
./.
====================
The/DT
value/NN
was/VBD
calculated/VBN
as/IN
the/DT
ratio/NN
of/IN
the/DT
number/NN
of/IN
CpGs/NNS
on/IN
the/DT
chromatin/NN
states/NNS
among/IN
the/DT
total/JJ
differentially/RB
methylated/VBN
CpGs/NNS
divided/VBN
by/IN
the/DT
ratio/NN
of/IN
chromatin/NN
states/NNS
among/IN
all/DT
CpGs/NNS
./.
====================
p-values/NNS
from/IN
Fisher/NN
's/POS
exact/JJ
tests/NNS
are/VBP
shown/VBN
at/IN
the/DT
upper/JJ
side/JJ
on/IN
each/DT
bar/JJ
./.
====================
(/(
B/NN
)/)
Proportions/NNS
of/IN
obese-hypermethlylated/VBN
and/CC
obese-hypomethylated/VBN
CpG/NN
sites/NNS
are/VBP
shown/VBN
across/IN
15/CD
chromHMM-annotated/JJ
chromatin/NN
states/NNS
./.
====================
Clinical/JJ
information/NN
for/IN
the/DT
12/CD
individuals/NNS
====================
